Cancer woes could force huge company into Chapter 11 bankruptcy
A major multinational company is considering bankruptcy for one of its divisions after a high-profile acquisition led to more than 160,000 costly cancer-related lawsuits.
In the industry world, it’s all about the appropriate strategy.
Two carefully linked instruments for say are company strategy and M&A (merger and acquisition) strategy.
Company strategy sets a firm’s overall path, from colossal targets to particular targets treasure diversification or efficiency. As soon as defined, M&A mode helps these targets through focused acquisitions or mergers.
Connected: One other fundamental trucking firm data for Chapter 11 monetary catastrophe
Acquisition selections should be meticulously thought through and shaped by the firm’s broader strategy.
As an illustration, Amazon’s (AMZN) acquisition of Complete Foods aimed to enhance the retail giant’s market presence and distribution capacities, whereas Disney’s (DIS) acquisition of twenty first Century Fox had a draw to amplify its boom material and streaming providers and products, constant with Institute for Mergers Acquisitions and Alliances.
Since 2000, there had been more than 790,000 transactions globally with a identified tag of more than $57 trillion.
These deals offer substantial strategic advantages, nonetheless to boot they carry dangers and challenges, at the side of cultural integration, regulatory hurdles, and monetary dangers, amongst others.
On occasion negative selections salvage a abundant tag.
One pharmaceutical firm obtained a super agricultural industry with about 170,000 serious court docket cases in opposition to it. Now, the parent firm is pondering a Chapter 11 monetary catastrophe for this unit to decide the closing court docket cases. Image source: Hitij/Getty Photos
Bayer should take care of Monsanto’s 67,000 closing cancer court docket cases
In 2018, German multinational pharmaceutical and biotechnology firm, Bayer AG (BAYRY) , obtained American agrochemical and agricultural biotech firm Monsanto for $63 billion.
Since then, Bayer has been enthusiastic about litigation linked to ancient Monsanto products corresponding to the herbicides glyphosate and dicamba, to boot to polychlorinated biphenyls (PCBs) feeble in electrical instruments, paints, and coatings.
Extra appropriate battles:
- Bancor data patent infringement lawsuit in opposition to Uniswap
- SEC pushes inspire on surprise filing in Ripple lawsuit
- Biggest RV dealer all of the sudden shuts down retailer amid flag controversy
As of May 2025, Monsanto has reached settlements in shut to 100,000 Roundup court docket cases, paying about $11 billion. In court docket cases, plaintiffs claim the glyphosate weedkiller Roundup causes cancer.
Roughly 67,000 instances remain pending, constant with the Lawsuit Recordsdata Middle.
Bayer weighs Chapter 11 monetary catastrophe in case settlements fail
Because it works to decide the closing Roundup instances, the German pharmaceutical giant is also weighing a potential monetary catastrophe for its Monsanto-linked agricultural division if the present resolution efforts topple through, completely reported the Wall Facet freeway Journal, citing people conscious of the matter.
Per the document, Bayer is searching to handle among the most court docket cases in Missouri declare court docket, the set up the majority of the instances are pending, whereas making ready a Chapter 11 filing for Monsanto.
A monetary catastrophe would stop court docket cases in opposition to the division and originate a path to settling its fragment of Roundup-associated liability in monetary catastrophe court docket, writes Insurance Journal.
Bayer has brought in appropriate experts from Latham & Watkins and consultants from AlixPartners to explore potential techniques.
In April, Bayer petitioned the U.S. Supreme Court to rule that federal law preempts hundreds of declare court docket cases claiming it failed to warn users that Roundup may arrangement off cancer.
The German pharmaceutical firm argues that for the reason that Environmental Protection Company (EPA) approved Roundup’s brand without a cancer warning, states can’t require additional warnings, reported The Associated Press.
At the identical time, Bayer is pushing for declare law to give protection to it from further court docket cases, and even supposing it denies claims that the weedkiller causes cancer, it has arrangement aside $16 billion for settlements.
Connected: Timid airline data monetary catastrophe, vacationers may no longer obtain refunds
In early March, Bayer suggested farmers and stores that it'll want to cease Roundup gross sales, which may possibly ride away U.S. farmers reliant on imported glyphosate from China, reported Farms, citing The Wall Facet freeway Journal.
Bayer’s CEO Bill Anderson suggested the outlet that surely one of his targets when he took the role in 2023 used to be to acquire the glyphosate litigation under adjust by 2026. Anderson added that litigation prices salvage precipitated $2 billion to $3 billion in losses a one year, infrequently eclipsing Bayer’s agriculture study and pattern funds.
After petitioning the U.S. Supreme Court, Bayer warned that the formulation forward for American agriculture is at stake.
What's Your Reaction?
